<DOC>
	<DOCNO>NCT00103428</DOCNO>
	<brief_summary>V-0039 Phase 1/2 dose escalation trial CG7870 combination Docetaxel metastatic hormone-refractory patient receive chemotherapy . All patient receive docetaxel . In dose escalation phase study , patient receive treatment intravenously CG7870 one four dose level . In Phase 2 portion study , additional patient add maximum tolerated dose determine Phase 1 .</brief_summary>
	<brief_title>Intravenous CG7870 Combination With Docetaxel Patients With Metastatic Hormone-Refractory Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Histologically confirm adenocarcinoma prostate Metastatic prostate cancer deem unresponsive refractory hormone therapy ( discontinuation antiandrogen therapy ) Detectable metastasis bone scan , and/or CT scan , and/or MRI , and/or CXR ECOG performance status 01 Transitional cell , small cell , neuroendocrine , squamous cell prostate cancer History deep vein thrombosis pulmonary embolus Patients take anticoagulant ( coumadin Heparin ) . The use aspirin study acceptable . History bleed disorder recent clinically significant bleed Seropositive HIV History Hepatitis B , Hepatitis C , chronic liver disease Prior gene therapy immunotherapy Prior chemotherapy prostate cancer Radiation therapy within 4 week first treatment . History myocardial infarction within 6 month first treatment History cerebrovascular accident History previous malignancy , except follow : adequately treat basal cell squamous cell skin cancer , superficial bladder cancer , adequately treated Stage I II cancer currently complete remission , cancer complete remission least 5 year Evidence active prostatitis Known hypersensitivity docetaxel drug formulate polysorbate 80</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>chemotherapy</keyword>
	<keyword>prostate cancer</keyword>
	<keyword>cancer</keyword>
	<keyword>metastatic</keyword>
	<keyword>hormone refractory</keyword>
	<keyword>chemotherapy naive</keyword>
	<keyword>dose escalation</keyword>
</DOC>